Tumor lysis syndrome after induction chemotherapy of small-cell bronchogenic carcinoma.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D002283:Carcinoma, Bronchogenic / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D018288:Carcinoma, Small Cell / Q000150:complications* / Q000188:drug therapy / Q000473:pathology; D005260:Female; D006801:Humans; D006947:Hyperkalemia / Q000150:complications*; D006996:Hypocalcemia / Q000150:complications*; D008175:Lung Neoplasms / Q000150:complications* / Q000188:drug therapy; D008875:Middle Aged; D010710:Phosphates / Q000097:blood*; D013577:Syndrome; D014527:Uric Acid / Q000097:blood
D000970:Antineoplastic Agents; D010710:Phosphates; D014527:Uric Acid